Understanding health insurance coverage for ColoPrint in the USA

Our mission is to ensure all colon cancer patients have access to important, and clinically relevant molecular diagnostic testing empowering patients and physicians to make the most informed treatment decisions.  Agendia understands that costs associated with a patient’s diagnosis, treatment, and management of colon cancer can potentially pose a financial hardship which may influence a patient’s decision in selecting  diagnostic and treatment options. The following information will inform you about financial responsibility associated with performing any of Agendia’s tests..